BEAM logo

Combined Holdings of BEAM in All ARK ETFs

Beam Therapeutics

BEAM Therapeutics is a biotechnology company focused on developing precision genetic medicines using base editing technology to treat various serious diseases at the molecular level. The company generates revenue through partnerships, collaborations, and potential future commercialization of its innovative therapies.

Trades of BEAM in All Ark ETFs

The ten most recent trades of Beam Therapeutics in all the Ark ETFs ETF.View all trades

Date
Direction
Market Value
% of Position
% of ETF
Dec 18, 2024Buy$2,744,7372.18%0.04%
Dec 18, 2024Buy$436,3480.91%0.04%
Dec 17, 2024Buy$2,234,6791.71%0.03%
Dec 17, 2024Buy$364,8120.72%0.03%
Dec 16, 2024Buy$895,1540.70%0.01%
Dec 16, 2024Buy$147,5390.30%0.01%
Dec 13, 2024Buy$131,2810.27%0.01%
Dec 13, 2024Buy$823,3920.67%0.01%
Nov 18, 2024Buy$346,1340.83%0.03%
Nov 18, 2024Buy$2,538,9012.39%0.04%